Next Article in Journal
A Sandwich ELISA for Quality Control of PCV2 Virus-like Particles Vaccine
Next Article in Special Issue
Adverse Effects of Sinopharm COVID-19 Vaccine among Vaccinated Medical Students and Health Care Workers
Previous Article in Journal
Exploration of Correlations between COVID-19 Vaccination Choice and Public Mental Health Using Google Trend Search
Previous Article in Special Issue
Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study
 
 
Article
Peer-Review Record

Peripheral Nervous System Adverse Events after the Administration of mRNA Vaccines: A Systematic Review and Meta-Analysis of Large-Scale Studies

Vaccines 2022, 10(12), 2174; https://doi.org/10.3390/vaccines10122174
by Yu-Hsin Lai 1,†, Hong-Yu Chen 2,†, Hsin-Hui Chiu 1,3, Yi-No Kang 1,4,* and Shi-Bing Wong 1,5,*
Reviewer 1: Anonymous
Vaccines 2022, 10(12), 2174; https://doi.org/10.3390/vaccines10122174
Submission received: 22 November 2022 / Revised: 9 December 2022 / Accepted: 15 December 2022 / Published: 17 December 2022
(This article belongs to the Special Issue Vaccination Related Adverse Reaction)

Round 1

Reviewer 1 Report

This review and meta-analysis of the risk of peripheral nervous system (PNS) adverse events after the administration of mRNA vaccines against COVID-19 follows standard protocols for such studies. Overall, the paper is well organized, well written, and the analyses appear to be well done. 

Here are a couple of items to attend to in a revision:

First, in order to facilitate accessibility of the paper's contents to readers of Vaccines who may not be as well informed as the authors about the intricacies of the PNS adverse events that are the focus of the study, it would be good to include an Appendix that gives brief definitions and descriptions of Bell’s palsy and the Guillain–Barré syndrome (symptoms, causes, etc.). 

Second, in the Abstract and Conclusion sections of the paper, it would be good to give a general numeric indication of the orders of magnitude of the "rarity" and "higher risk". These are very small, but, again, some indication thereof will be useful information for readers.

 

 

 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

The manuscript represents an interesting analysis concerning the unwanted effects of mRNA vaccine. However, several issues must be addressed before considering the manuscript for publication.

-The first issue is related with the low number of trials, some of them difficult to combine based on the approaches and analysis.

-The second issue refers to a bias found in the first figure of the supplemental material, which affects the table and conclusions. The rationale for analyzing the effect of each dose but the manuscript of McMurry differs from the others and should be carefully screened. 

-The conclusions are overstated based on the low number of manuscripts analysed. 

-The limitations of the study are several. and should be stated. 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

The authors have made the requested changes in the manuscript. It is now suitable for publication

Back to TopTop